Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2026)

Pediatrix Medical (MD) has 9 years of Long-Term Deferred Tax data on file, last reported at $65.7 million in Q1 2026.

• Quarterly Long-Term Deferred Tax fell 33.88% year-over-year to $65.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.7 million (down 33.88% YoY) and the FY2025 annual result came in at $73.9 million, down 69.63% from the prior year.
• Long-Term Deferred Tax eased to $65.7 million in Q1 2026 per MD's latest filing, from $73.9 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $696.6 million in Q4 2022 and bottomed at $65.7 million in Q1 2026.
• The 5-year median for Long-Term Deferred Tax is $99.4 million (2025), against an average of $137.9 million.
• The widest annual swing landed in 2023, when Long-Term Deferred Tax sank 90.17%; it then jumped 255.34% in 2024.
• Tracing MD's Long-Term Deferred Tax over 5 years: stood at $696.6 million in 2022, then slumped by 90.17% to $68.5 million in 2023, then jumped by 255.34% to $243.4 million in 2024, then plunged by 69.63% to $73.9 million in 2025, then dropped by 11.11% to $65.7 million in 2026.
• Per Business Quant, the three latest MD Long-Term Deferred Tax figures stand at $65.7 million (Q1 2026), $73.9 million (Q4 2025), and $79.8 million (Q3 2025).

Peer Comparison